• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于L-天冬酰胺酶治疗监测的超高效液相色谱-串联质谱法的开发。

Development of a UPLC-MS/MS method for the therapeutic monitoring of L-asparaginase.

作者信息

Jeong Hyeon-Cheol, Kim Therasa, Yang Deok-Hwan, Shin Kwang-Hee

机构信息

College of Pharmacy, Research Institute of Pharmaceutical Sciences, Kyungpook National University, Daegu 41566, Korea.

Department of Hematology, Chonnam National University Hwasun Hospital, Hwasun 58128, Korea.

出版信息

Transl Clin Pharmacol. 2018 Sep;26(3):134-140. doi: 10.12793/tcp.2018.26.3.134. Epub 2018 Sep 14.

DOI:10.12793/tcp.2018.26.3.134
PMID:32055563
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6989229/
Abstract

This study aimed to develop a UPLC-MS/MS method for determining plasma levels of L-aspartic acid and L-asparagine and the activity of L-asparaginase. L-aspartic acid, L-asparagine, and L-aspartic acid-2,3,3-d were extracted from human plasma by protein precipitation with sulfosalicylic acid (30%, v/v). The plasma samples were analyzed using an Imtakt Intrada amino acid analysis column with 25 mM ammonium formate and 0.5% formic acid in acetonitrile as the mobile phase with step gradient method at a flow rate of 0.5 mL/min. The injection volume was 5 µL, and the total run time was 15 min. Inter- and intra-batch accuracies (%) ranged from 96.62-106.0% for L-aspartic acid and 89.85-104.8%, for L-asparagine, and the coefficient of variation (CV%) did not exceed 7%. The validation results for L-aspartic acid and L-asparagine satisfied the specified criterion, however, the results for L-asparaginase activity assay showed a borderline validity. This study could be a foundation for further development of therapeutic drug monitoring systems using UPLC-MS/MS.

摘要

本研究旨在开发一种超高效液相色谱-串联质谱法,用于测定血浆中L-天冬氨酸和L-天冬酰胺的水平以及天冬酰胺酶的活性。采用30%(v/v)磺基水杨酸通过蛋白质沉淀法从人血浆中提取L-天冬氨酸、L-天冬酰胺和L-天冬氨酸-2,3,3-d。血浆样品采用Imtakt Intrada氨基酸分析柱进行分析,以25 mM甲酸铵和0.5%甲酸的乙腈溶液为流动相,采用梯度洗脱法,流速为0.5 mL/min。进样量为5 μL,总运行时间为15 min。L-天冬氨酸的批间和批内准确度(%)范围为96.62 - 106.0%,L-天冬酰胺为89.85 - 104.8%,变异系数(CV%)不超过7%。L-天冬氨酸和L-天冬酰胺的验证结果符合规定标准,然而,天冬酰胺酶活性测定结果显示有效性处于临界状态。本研究可为进一步开发基于超高效液相色谱-串联质谱的治疗药物监测系统奠定基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/072f/6989229/b0a5e291fa8e/tcp-26-134-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/072f/6989229/3ee21ed211d7/tcp-26-134-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/072f/6989229/a7cfdcf75b77/tcp-26-134-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/072f/6989229/b0a5e291fa8e/tcp-26-134-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/072f/6989229/3ee21ed211d7/tcp-26-134-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/072f/6989229/a7cfdcf75b77/tcp-26-134-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/072f/6989229/b0a5e291fa8e/tcp-26-134-g003.jpg

相似文献

1
Development of a UPLC-MS/MS method for the therapeutic monitoring of L-asparaginase.一种用于L-天冬酰胺酶治疗监测的超高效液相色谱-串联质谱法的开发。
Transl Clin Pharmacol. 2018 Sep;26(3):134-140. doi: 10.12793/tcp.2018.26.3.134. Epub 2018 Sep 14.
2
An isocratic fluorescence HPLC assay for the monitoring of l-asparaginase activity and l-asparagine depletion in children receiving E. colil-asparaginase for the treatment of acute lymphoblastic leukaemia.一种等度荧光高效液相色谱法,用于监测接受大肠杆菌L-天冬酰胺酶治疗急性淋巴细胞白血病的儿童的L-天冬酰胺酶活性和L-天冬酰胺消耗情况。
Biomed Chromatogr. 2009 Feb;23(2):152-9. doi: 10.1002/bmc.1096.
3
Development and Validation of a Hydrophilic Interaction Liquid Chromatography Tandem Mass Spectrometry Method for the Determination of Asparagine in Human Serum.用于测定人血清中天冬酰胺的亲水作用液相色谱串联质谱法的开发与验证
Int J Anal Chem. 2020 Feb 28;2020:6980392. doi: 10.1155/2020/6980392. eCollection 2020.
4
Development and validation of an UPLC-MS/MS assay for quantitative analysis of the ghrelin receptor inverse agonist PF-5190457 in human or rat plasma and rat brain.用于定量分析人或大鼠血浆及大鼠脑中胃饥饿素受体反向激动剂PF-5190457的超高效液相色谱-串联质谱法的建立与验证
Anal Bioanal Chem. 2015 Jul;407(19):5603-13. doi: 10.1007/s00216-015-8730-2. Epub 2015 May 7.
5
A novel and sensitive UPLC-MS/MS method to determine mequitazine in rat plasma and urine: Validation and its application to pharmacokinetic studies.一种测定大鼠血浆和尿液中甲喹嗪的新型灵敏超高效液相色谱-串联质谱法:方法验证及其在药代动力学研究中的应用。
Biomed Chromatogr. 2019 Oct;33(10):e4627. doi: 10.1002/bmc.4627. Epub 2019 Jul 15.
6
Development and validation of a UPLC-MS/MS method for determination of motesanib in plasma: Application to metabolic stability and pharmacokinetic studies in rats.建立并验证了一种用于血浆中莫特沙尼检测的 UPLC-MS/MS 方法:在大鼠中的代谢稳定性和药代动力学研究中的应用。
J Pharm Biomed Anal. 2019 Mar 20;166:244-251. doi: 10.1016/j.jpba.2019.01.023. Epub 2019 Jan 14.
7
UPLC-MS/MS assay for the simultaneous quantification of carvedilol and its active metabolite 4'-hydroxyphenyl carvedilol in human plasma to support a bioequivalence study in healthy volunteers.采用超高效液相色谱-串联质谱法同时测定人血浆中卡维地洛及其活性代谢物4'-羟基苯基卡维地洛,以支持在健康志愿者中开展的生物等效性研究。
Biomed Chromatogr. 2013 Aug;27(8):974-86. doi: 10.1002/bmc.2889. Epub 2013 Mar 11.
8
UPLC-MS/MS method for the simultaneous quantification of sofosbuvir, sofosbuvir metabolite (GS-331007) and daclatasvir in plasma of HIV/HCV co-infected patients.用于同时定量检测HIV/HCV合并感染患者血浆中索磷布韦、索磷布韦代谢物(GS-331007)和达卡他韦的超高效液相色谱-串联质谱法。
J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Jan 15;1073:183-190. doi: 10.1016/j.jchromb.2017.12.018. Epub 2017 Dec 12.
9
Polyethylene glycol-L-asparaginase and L-asparaginase studies in rabbits.
Drug Metab Dispos. 1988 Jan-Feb;16(1):27-9.
10
Optimization of a Precolumn OPA Derivatization HPLC Assay for Monitoring of l-Asparagine Depletion in Serum during l-Asparaginase Therapy.用于监测左旋天冬酰胺酶治疗期间血清中左旋天冬酰胺消耗的柱前OPA衍生化高效液相色谱法的优化
J Chromatogr Sci. 2018 Oct 1;56(9):794-801. doi: 10.1093/chromsci/bmy053.

引用本文的文献

1
Exploring the potential of bacterial-derived EVs for targeted enzyme replacement therapy: mechanisms, applications, and future directions.探索细菌衍生细胞外囊泡用于靶向酶替代疗法的潜力:作用机制、应用及未来方向。
Arch Microbiol. 2025 Apr 10;207(5):118. doi: 10.1007/s00203-025-04294-3.
2
Metabolites Profiling and In Vitro Biological Characterization of Different Fractions of sp. Marine Sponge from the Red Sea Egypt.埃及红海海洋海绵不同部分的代谢产物分析及体外生物学特性研究。
Molecules. 2023 Feb 8;28(4):1643. doi: 10.3390/molecules28041643.
3
Immobilization and Characterization of L-Asparaginase over Carbon Xerogels.

本文引用的文献

1
Quantitative analysis of endogenous compounds.内源性化合物的定量分析。
J Pharm Biomed Anal. 2016 Sep 5;128:426-437. doi: 10.1016/j.jpba.2016.06.017. Epub 2016 Jun 11.
2
Pharmacogenetics predictive of response and toxicity in acute lymphoblastic leukemia therapy.药物遗传学对急性淋巴细胞白血病治疗中反应和毒性的预测作用
Blood Rev. 2015 Jul;29(4):243-9. doi: 10.1016/j.blre.2015.01.001. Epub 2015 Jan 10.
3
Asparaginase pharmacokinetics and implications of therapeutic drug monitoring.天冬酰胺酶的药代动力学及治疗药物监测的意义。
L-天冬酰胺酶在碳干凝胶上的固定化及表征
BioTech (Basel). 2022 Apr 14;11(2):10. doi: 10.3390/biotech11020010.
4
Chemical Constituent Analysis of L. Using Ultra-High-Performance Liquid Chromatography Coupled with Quadrupole-Orbitrap High-Resolution Mass Spectrometry.采用超高效液相色谱-四极杆轨道阱高分辨质谱联用技术分析 L.中的化学成分。
Molecules. 2022 May 20;27(10):3299. doi: 10.3390/molecules27103299.
Leuk Lymphoma. 2015;56(8):2273-80. doi: 10.3109/10428194.2014.1003056. Epub 2015 Mar 11.
4
A prospective study on drug monitoring of PEGasparaginase and Erwinia asparaginase and asparaginase antibodies in pediatric acute lymphoblastic leukemia.培门冬酶和欧文氏菌门冬酰胺酶及门冬酰胺酶抗体在儿童急性淋巴细胞白血病中药物监测的前瞻性研究。
Blood. 2014 Mar 27;123(13):2026-33. doi: 10.1182/blood-2013-10-534347. Epub 2014 Jan 21.
5
L-asparaginase: an effective agent in the treatment of acute lymphoblastic leukemia.L-天冬酰胺酶:治疗急性淋巴细胞白血病的一种有效药物。
Leuk Lymphoma. 2014 Feb;55(2):256-62. doi: 10.3109/10428194.2013.803224. Epub 2013 Jun 14.
6
Surrogate matrix and surrogate analyte approaches for definitive quantitation of endogenous biomolecules.用于内源性生物分子精确定量的替代基质和替代分析物方法。
Bioanalysis. 2012 Oct;4(19):2343-56. doi: 10.4155/bio.12.200.
7
L-asparaginase treatment in acute lymphoblastic leukemia: a focus on Erwinia asparaginase.培门冬酶治疗急性淋巴细胞白血病:以欧文氏菌门冬酰胺酶为重点。
Cancer. 2011 Jan 15;117(2):238-49. doi: 10.1002/cncr.25489. Epub 2010 Sep 7.
8
Therapeutic drug monitoring of asparaginase in the ALL-BFM 2000 protocol between 2000 and 2007.2000 年至 2007 年 ALL-BFM 2000 方案中 asparaginase 的治疗药物监测。
Pediatr Blood Cancer. 2010 Jul 1;54(7):952-8. doi: 10.1002/pbc.22417.
9
Advances in amino acid analysis.氨基酸分析的进展
Anal Bioanal Chem. 2009 Jan;393(2):445-52. doi: 10.1007/s00216-008-2421-1. Epub 2008 Oct 9.
10
An isocratic fluorescence HPLC assay for the monitoring of l-asparaginase activity and l-asparagine depletion in children receiving E. colil-asparaginase for the treatment of acute lymphoblastic leukaemia.一种等度荧光高效液相色谱法,用于监测接受大肠杆菌L-天冬酰胺酶治疗急性淋巴细胞白血病的儿童的L-天冬酰胺酶活性和L-天冬酰胺消耗情况。
Biomed Chromatogr. 2009 Feb;23(2):152-9. doi: 10.1002/bmc.1096.